Self DNA from Lymphocytes That Have Undergone Activation-Induced Cell Death Enhances Murine B Cell Proliferation and Antibody Production

被引:3
作者
Lu, Qing [1 ]
Wang, Ji-Yang [1 ,2 ]
Wang, Luman [1 ]
Jiang, Xuechao [1 ]
Chu, Yiwei [1 ,2 ]
机构
[1] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Key Lab Med Mol Virol MOE MOH, Shanghai 200433, Peoples R China
[2] Fudan Univ, Biotherapy Res Ctr, Shanghai 200433, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 10期
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; SHORT-LIVED PLASMABLASTS; MARGINAL-ZONE; GERMINAL CENTER; INCREASED FREQUENCY; AUTOIMMUNE-DISEASE; IMMUNE-COMPLEXES; DYING CELLS; NZB/W MICE;
D O I
10.1371/journal.pone.0109095
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Systemic lupus erythematosus (SLE) is characterized by prominent autoinflammatory tissue damage associated with impaired removal of dying cells and DNA. Self DNA-containing immune complexes are able to activate both innate and adaptive immune responses and play an important role in the maintenance and exacerbation of autoimmunity in SLE. In this study, we used DNA from lymphocytes that have undergone activation-induced cell death (ALD-DNA) and analyzed its role on the activation and differentiation of B cells from normal BALB/c mice as well as lupus-prone MRL+/+ and MRL/lpr mice. We found that ALD-DNA directly increased the expression of costimulatory molecules and the survival of naive B cells in vitro. Although ALD-DNA alone had little effect on the proliferation of naive B cells, it enhanced LPS-activated B cell proliferation in vitro and in vivo. In addition, ALD-DNA increased plasma cell numbers and IgG production in LPS-stimulated cultures of naive B cells, in part via enhancing IL-6 production. Importantly, B cells from lupus mice were hyperresponsive to ALD-DNA and/or LPS relative to normal control B cells in terminal plasma cell differentiation, as evidenced by increases in CD138(+) cell numbers, IgM production, and mRNA levels of B lymphocyte-induced maturation protein-1 (Blimp-1) and the X-box binding protein 1 (XBP1). Furthermore, ALD-DNA enhanced CD40-activated naive B cell proliferation. Collectively, these data indicate that self DNA can serve as a DAMP (damage-associated molecular pattern) that cooperates with signals from both innate and adaptive immunity to promote polyclonal B cell activation, a common characteristic of autoimmune diseases.
引用
收藏
页数:12
相关论文
共 65 条
[1]   Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus [J].
Anolik, JH ;
Barnard, J ;
Cappione, A ;
Pugh-Bernard, AE ;
Felgar, RE ;
Looney, RJ ;
Sanz, I .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3580-3590
[2]   Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus [J].
Arce, E ;
Jackson, DG ;
Gill, MA ;
Bennett, LB ;
Banchereau, J ;
Pascual, V .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :2361-2369
[3]   Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA [J].
Barton, GM ;
Kagan, JC ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2006, 7 (01) :49-56
[4]  
Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO
[5]  
2-K
[6]   Maintenance of serological memory by polyclonal activation of human memory B cells [J].
Bernasconi, NL ;
Traggiai, E ;
Lanzavecchia, A .
SCIENCE, 2002, 298 (5601) :2199-2202
[7]   A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells [J].
Bernasconi, NL ;
Onai, N ;
Lanzavecchia, A .
BLOOD, 2003, 101 (11) :4500-4504
[8]   Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides [J].
Brummel, R ;
Lenert, P .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :2429-2434
[9]   Mannose-Binding Lectin Blunts Macrophage Polarization and Ameliorates Lupus Nephritis [J].
Cai, Yanxing ;
Zhang, Weijuan ;
Xiong, Sidong .
PLOS ONE, 2013, 8 (04)
[10]  
Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO